Tc-99m Depreotide Scintigraphy of Low-Grade Non-Hodgkin's Lymphoma

Clinical Nuclear Medicine

Volumn 28, Issue 6, 2003, Pages 503-505

  Montilla Soler, Jaime L ^a   Rexroad, Jason T ^a   Bridwell, Robert S ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPREOTIDE TC 99M; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN; TECHNETIUM COMPLEX;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOLLICULAR LYMPHOMA; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, FOLLICULAR; MIDDLE AGED; NEOPLASM STAGING; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0041733880     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200306000-00014     Document Type: Article

References (10)

1. Rhem P: Radionuclide evaluation of patients with lymphoma. Radiol Clin North Am 39:957, 2001.
2. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting. J Clin Oncol 17:3835, 1999.
3. Gallamin A, Biggi A, Fruttero A, et al: Revisiting the prognostic role of gallium scintigraphy in low-grade Non-Hodgkin's lymphoma. Eur J Nucl Med 24:1499, 1997.
4. Bar-Shalom R, Mor M, Yefremov N, et al: The value of Ga-67 scintigraphy and F18 fluorodeoxyglucose positron emission tomography in staging and monitoring response to lymphoma treatment. Semin Nucl Med 21:177, 2001.
5. 18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 12:825, 2001.
6. Hoffmann M, Kletter K, Diemling M, et al: Positron emission tomography with fluorine-18-2-fluoro-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) type. Ann Oncol 10:1185, 1999.
7. Virgolini I, Leimer M, Handmaker H, et al: Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, Tc99m-P829. Cancer Res 58:1850, 1998.
8. Reubi JC, Waser B, Van Hagen M, et al: In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 50:895, 1992.
9. Raderer M, Valencak J, Pfeffel F, et al: Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa associated lymphoid tissue type. J Natl Cancer Inst 91:716, 1999.
10. Lugtenburg PJ, Lowenberg B, Valkema R, et al: Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas. J Nucl Med 42:222, 2001.